Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison

Pui S. Tan, Benjamin Haaland, Alberto J. Montero, Christos E. Kyriakopoulos, Gilberto Lopes

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison'. Together they form a unique fingerprint.

Medicine & Life Sciences